CClinicalTrials.gg
CompletedNCT02969291Updated Jul 17, 2019

A Home-Based Study to Enhance Activity in Breast Cancer Survivors

An interventional study of Reduced Sedentary Time Intervention (RSTI) in Breast Cancer, sponsored by Baystate Medical Center. Completed at 1 site in United States. Open to female participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-07-17.

Sponsored by Baystate Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
20 Years to 80 Years
Sex
Female
01

Study summary

There is a well-documented association between physical activity \& risk for breast cancer development and recurrence. It is known that exercise interventions have been effective at increasing physical activity levels in breast cancer survivors. Knowing that breast cancer survivors are less active than non-cancer patients, a less active lifestyle places them at risk of obesity and poor overall health, which in turn also increases risk of cancer and cancer recurrence. Not all the reasons for the risk reduction are clear, however it is known that hormones and other inflammatory markers play a role.

This study has three goals:

  1. To investigate the feasibility of a home intervention designed to reduce sedentary behavior.
  2. Describe the effects of the intervention on levels of sedentary behavior, physical activity, and symptoms.
  3. Assess cost of the intervention.
Read the detailed description

There is a well-documented association between physical activity and risk for breast cancer development and recurrence. Exercise training interventions have been effective at increasing physical activity levels in breast cancer survivors, however they require 1) a large degree of patient initiative to achieve positive health outcomes associated with sustained behavioral change and 2) facilities and oversight that may be prohibitive in a clinical setting. Although most activity-based research to date has focused on increasing levels of moderate to vigorous physical activity (MVPA) for breast cancer survivors, large epidemiological studies suggest that breast cancer survivors are also more sedentary when compared to non-cancer controls. A recent meta-analysis of controlled intervention trials designed to promote physical activity among sedentary cancer survivors found that none of the trials within the scope of the review succeeded in achieving 75% or better adherence to prescribed exercise guidelines, leading the authors to question whether shifting the target of intervention from MVPA to reductions in sedentary time might be a more realistic goal. Recent research suggests that interventions designed to reduce sedentary time in breast cancer survivors have the potential to yield clinically meaningful health benefits, especially for individuals at higher risk for sedentary behaviors, however the optimal method of intervention is not clear.

Aim 1: Feasibility of the intervention Assess the feasibility of an intervention designed to reduce sedentary behavior in breast cancer survivors. The behavioral intervention will involve the review of a 7-day baseline snapshot of sedentary behavior and physical activity patterns, combined with tailored activity prompts described over the following 6 weeks.

Aim 2: Effects of the intervention Aim 2a: Describe a preliminary range of effect sizes of the intervention on levels of sedentary behavior, physical activity and symptoms of cancer survivorship (e.g. cancer related fatigue).

Aim 2b: Evaluate the relationship between change in sedentary behavior and change in cancer-relevant outcomes, such as fatigue and biomarkers of cancer recurrence (e.g. IGF-1, Leptin), following the reduced sedentary time intervention.

Aim 3: Assessment of intervention components Aim 3a: Quantitatively assess overall cost of the intervention and its individual components, dose delivered and dose received by intervention participants Aim 3b: Quantitatively describe intervention participants' perspectives on the impact of the individual intervention components, including which components appeared most useful for reducing sedentary time.

02

Conditions studied

  • Breast Cancer

Browse trials for

03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 13 is below the median of 72 across 9,302 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Baystate Medical Center is the lead sponsor of 47 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Stage I-III breast cancer survivors 20-80 who have completed primary treatment (surgery, radiation and/or chemotherapy) greater than 6 months but less than 5 years ago. Patients may be on adjuvant hormonal therapy
  • BMI > 25 (overweight or class I/II obese)
  • Not meeting current guidelines for regular exercise as defined by less than 150 minutes a week of moderate to vigorous physical activity
  • No gain or loss of >10% body weight over the prior 6 months.

Exclusion criteria

Exclusion Criteria:

  • Known diabetes
  • Known coronary artery disease
  • Pregnancy
  • Any injury that would limit mobility or require use of assisted mobility devices
  • Weight gain or loss of >10% body weight over the prior 6 months
  • Greater than 150 minutes a week of moderate to vigorous physical activity
  • Inability to provide informed consent
  • Non-english speaking
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Other
    Reduced Sedentary Time Intervention

    Reduced Sedentary Time Intervention (RSTI)

    Behavioral: Reduced Sedentary Time Intervention (RSTI)

Interventions

  • BehavioralReduced Sedentary Time Intervention (RSTI)

    Following 7 days of baseline activity monitoring a study investigator will download the information from the monitor, evaluate the periods of sedentary behavior and create a tailored RSTI for each participant. For example, the investigator may notice a long stretch of sitting in the evening following a meal and identify several exercises that can be done indoors during that time, or if the participant is amiable to walking breaks and a period after work is identified the investigator might suggest the appropriate walking activity at that time. This program has been successful in sedentary overweight office workers and investigators will use similar techniques.

06

What researchers measure

Primary outcomes

  1. Sedentary Time

    Change in minutes/day of sedentary time as recorded by ActivPal in all 25 participants pre and post intervention.

    Time frame: 8 weeks

Secondary outcomes

  1. Activity Level

    Change in Activity level as recorded by Actigraph monitor in all 25 participants

    Time frame: 8 weeks

  2. Glucose

    Change in fasting glucose ( mmol/L)in all 25 participants

    Time frame: 8 weeks

  3. Insulin

    Change in insulin (pmol/L) in all 25 participants

    Time frame: 8 weeks

  4. Total cholesterol

    Change in total cholesterol (mmol) in all 25 participants

    Time frame: 8 weeks

  5. High density lipoprotien cholesterol

    Change in high density lipoprotein cholesterol (mmol) in all 25 participants

    Time frame: 8 weeks

  6. Triglyceride

    Change in triglycerides (mmol) in all 25 participants

    Time frame: 8 weeks

  7. Body Mass Index

    Change in Body Mass Index (kg/m2) in all 25 participants

    Time frame: 8 weeks

  8. Waist Circumference

    Change in waist circumference in cm in all 25 participants

    Time frame: 8 weeks

  9. Systolic Blood pressure

    Change in systolic blood pressure measured in mmHg in all 25 participants

    Time frame: 8 weeks

  10. Diastolic Blood pressure

    Change in diastolic blood pressure measured in mmHg in all 25 participants

    Time frame: 8 weeks

  11. Cancer-related fatigue measured by change in PROMIS short form 8a in all 25 participants

    Time frame: 8 weeks

  12. Cancer-related fatigue as measured by change in Visual Analog scale in all 25 participants

    Time frame: 8 weeks

  13. Sedentary behavior self -efficacy

    Change in Sedentary Behavior Self-Efficacy Scale (modified from BARSE) in all 25 participants

    Time frame: 8 weeks

  14. Change in EORTC-QLQ-C30 scores in all 25 participants

    Time frame: 8 weeks

  15. Assessment of Intervention

    Change in Assessment of Intervention questions on a scale of 1-5 in all 25 participants

    Time frame: 8 weeks

07

Study locations

1 site
  • Baystate Medical Center
    Springfield, Massachusetts 01109, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02969291
Lead sponsor
Baystate Medical Center
Collaborators
University of Massachusetts, Amherst
Responsible party
Sponsor
First posted
Nov 21, 2016
Start date
Oct 2016
Primary completion
Oct 2018
Completion
Oct 2018
Last update
Jul 17, 2019

Study contacts

Grace Makari-Judson, MD
principal investigator · Baystate Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion